InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Perry Nicole D, Chief Executive Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 12 reports have been recorded. The latest transaction was filed on 2 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€3,1661,000 shares@ €3.16640.0001% mcap17.3% of flow
Common Stock
SEC:0001127602-21-022938·
€3,1661,000 shares@ €3.16640.0001% mcap8.7% of flow
Common Stock
SEC:0001127602-21-022938:0·
€3,1741,000 shares@ €3.1740.0001% mcap17.4% of flow
Common Stock
SEC:0001127602-21-021194·
€3,1741,000 shares@ €3.1740.0001% mcap8.7% of flow
Common Stock
SEC:0001127602-21-021194:0·
€2,6291,000 shares@ €2.62890.0001% mcap14.4% of flow
Common Stock
SEC:0001127602-21-019902·
€2,6291,000 shares@ €2.62890.0001% mcap7.2% of flow
Common Stock
SEC:0001127602-21-019902:0·
€3,0771,000 shares@ €3.07750.0001% mcap16.8% of flow
Common Stock
SEC:0001127602-21-018704·
€3,0771,000 shares@ €3.07750.0001% mcap8.4% of flow
Common Stock
SEC:0001127602-21-018704:0·
€3,1171,000 shares@ €3.11740.0001% mcap17.1% of flow
Common Stock
SEC:0001127602-21-015186·
€3,1171,000 shares@ €3.11740.0001% mcap8.5% of flow
Common Stock
SEC:0001127602-21-015186:0·
€3,1001,000 shares@ €3.10050.0001% mcap17.0% of flow
Common Stock
SEC:0001127602-21-014986·
€3,1001,000 shares@ €3.10050.0001% mcap8.5% of flow
Common Stock
SEC:0001127602-21-014986:0·
12 of 12 declarations
About Perry Nicole D
Nicole D. Perry is the Chief Executive Officer and Vice President - Accounting at Apellis Pharmaceuticals, Inc. She is responsible for the strategic and operational leadership of the company. Her expertise in accounting and business management is essential to support the company's growth and performance.
